mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.087 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.1 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.1 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.072 |
0.1 |